The Life Sciences Web Portal for German-speaking Europe
This is a free web portal for the life sciences in German-speaking Europe... » read more
- Innate Pharma: Patient Treated in Ph1/2 Trial with IPH2201 (2015-09-28)
• Trial conducted in Canada under NCIC sponsorship • Program rollout on track Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH) today announced that the first patient was treated in the Phase I/II trial testing IPH2201, a first-in-class ...
- Promethera Biosciences Appoints John Tchelingerian as CEO (2015-09-23)
John Tchelingerian, PhD, a well-recognized serial entrepreneur in the life sciences, brings scientific, clinical, deal-making and management experience to the management team and to the company Mont-Saint-Guibert, Belgium, 23 September, 2015 – Promethera Bioscie...
- Nabriva Therapeutics Closes $92.25m US IPO at Nasdaq (2015-09-23)
Nabriva Therapeutics AG announced today the closing of its initial public offering of 9,000,000 American Depositary Shares (ADSs), representing 900,000 of its common shares, at a public offering price of $10.25 per ADS, before underwriting discounts. All of the ADS...
- Horizon Discovery Announces Results for First Half of 2015 (2015-09-22)
Horizon Discovery Group plc (LSE: HZD), the international life science company supplying research tools to organisations engaged in genomics research and the development of personalised medicines, today announces its interim results for the six months ended 30 June...
- c-Lecta GmbH Appoints Harry Böhme as CFO (2015-09-22)
Harry Böhme joins c-LEcta’s management team as CFO and managing director. In his previous position, Harry was CFO at Novaled AG in Dresden and as such responsible for all legal and financial aspects of the preparation for an intended IPO at the Nasdaq, and finally ...
- Zedira Research Collaboration with Cardiff University (2015-09-22)
Zedira and Cardiff University have initiated a joint project addressing questions regarding the role of an enzyme called transglutaminase 6 in the pathophysiology of neurodegenerative diseases. This work builds on and extends previous successful collaborations betw...
- TxCell Reports Financial Results for the First Half of 2015 (2015-09-22)
TxCell SA (FR0010127662 – TXCL), a biotechnology company developing innovative, personalized T-cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, today reports its financial results for...
- Biametrics GmbH Completes €3.1m Series A Financing Round (2015-09-18)
Biametrics GmbH today announced the completion of their most recent financing round with €3.1 Million. Partners of the A Series Investment were LBBW Venture GmbH, MBG Mittelständische Beteiligungsgesellschaft BW, and KfW Bankengruppe. Together with seed investors H...
- Cevec, Généthon Develop Cell Lines Using CAP GT Technology (2015-09-17)
> Agreement enables fully scalable, industrial lentivirus vector production > Collaboration represents an important step in the roll-out of CEVEC’s strategy to position CAP®GT technology as the industrial standard for the production of lentiviral vectors for com...
- Lipid Therapeutics Licenses UC Compound to Nestlé (2015-09-16)
Nestlé Health Science to develop and commercialise LT-02 worldwide, except in Europe and Australia Lipid Therapeutics today announces that it has entered into a licensing agreement with Nestlé Health Science for exclusive rights to Lipid Therapeutics' LT-02 c...
Life-Sciences-Germany.com is your doorway to the life sciences in German-speaking Europe!
[LSG] provides free, up-to-date and structured access to
in Germany, Austria and Switzerland.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSG] is 100% Made in Germany!Start here with the latest News!
To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to email@example.com and simply fill the subject line with the word »LSG newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)